12.90
+2.22%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Phreesia
From its filings with the US Securities and Exchange Commission
Phreesia is based in Wilmington, Delaware and is incorporated in Delaware. Its shares trade on NYSE under the ticker PHR. The SEC classifies its business as business services, nec. In the fiscal year to 31 January 2026, it reported revenue of $480.6m and net income of $2.3m. At that date it held total assets of $663.8m and shareholders' equity of $337.2m.
Phreesia, Inc. ("Phreesia," "we," "our," or the "Company") was founded in 2005 and completed its initial public offering in July 2019. Phreesia provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Our platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum.
We serve a diverse group of healthcare organizations including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest and not-for-profit and other organizations. Our solutions support the patient journey from care discovery and scheduling through intake, payment, and post-visit follow-up. In fiscal year 2026, our platform facilitated approximately 180 million patient visits, representing approximately one in six ambulatory patient visits in the United States.
Quoted from its 10-K, filed 31 Mar 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Technology
- Listed since
- 18 Jul 2019
- Employees
- 1,789
- Website
- phreesia.com ↗
- Head office
- 1521 CONCORD PIKE, WILMINGTON, DE, 19803
- Incorporated in
- DE
- Classification
- Services-Business Services, NEC
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Mr. Michael WeintraubIndependent Chairman of the Board$372,497
- Mr. Chaim IndigChief Executive Officer, Director, since 2005$10.5m
- Mr. Balaji GandhiChief Financial Officer$4.5m
- Mr. Evan RobertsChief Operating Officer$4.5m
- Ms. Amy VanDuynSenior Vice President - Human Resources
- Mr. David LinetskySenior Vice President - Network Solutions$4.5m
- Ms. Allison HoffmanGeneral Counsel, Secretary$3.0m
- Mr. Edward CahillIndependent Director$232,449
- Dr. Lisa Egbuonu-DavisIndependent Director$229,164
- Ms. Lainie GoldsteinIndependent Director$234,949
- Ms. Gillian MunsonIndependent Director$257,449
- Mr. Ramin SayarIndependent Director$234,164
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 47
- Environment
- 8
- Social
- 70
- Governance
- 62
- Women in the workforce
- 52%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Phreesia Inc has a strong market presence and a solid brand reputation in the healthcare industry. The company offers innovative patient intake solutions that streamline administrative processes, allowing healthcare providers to enhance efficiency and patient experience.
- Phreesia's technology is user-friendly and provides comprehensive data analytics, empowering healthcare organizations to make informed decisions. The company has a scalable business model and a flexible platform that can be customized to meet the specific needs of different healthcare settings.
Weaknesses
- Phreesia faces intense competition in the healthcare technology sector, which puts pressure on pricing and may impact the company's market share. Additionally, Phreesia's reliance on third-party integrations and partnerships exposes it to potential disruptions or limitations in service provision.
- Although Phreesia has built a solid reputation, some potential clients may still be skeptical about adopting new technological solutions, leading to slower adoption rates and longer sales cycles.
Opportunities
- The increasing demand for digitization and automation in healthcare presents Phreesia with significant growth opportunities. The company can expand its offerings to include additional modules and features, such as telehealth integrations and remote patient monitoring, to stay ahead of market trends.
- Furthermore, Phreesia can explore partnerships with key industry stakeholders, such as electronic medical record (EMR) providers, to integrate its solutions seamlessly into existing healthcare ecosystems. This collaboration can enhance Phreesia's market reach and open doors for cross-selling opportunities.
Threats
- One of the potential threats for Phreesia is the presence of well-established competitors with similar products and services. The market entry of new disruptive technologies or the emergence of alternative solutions could also pose a challenge to Phreesia's market position and growth prospects.
- Additionally, regulatory changes in the healthcare industry, such as privacy and security requirements, may impose compliance burdens on Phreesia. Non-compliance or data breaches could damage the company's reputation and result in legal and financial consequences.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.